ARDAN, Taras, Monika BAXA, Božena LEVINSKÁ, Miroslava SEDLÁČKOVÁ, The Duong NGUYEN, Jiří KLÍMA, Štefan JUHÁS, Jana JUHÁSOVÁ, Petra ŠMATLÍKOVÁ, Petra VOCHOZKOVÁ, Jan MOTLÍK and Zdenka ELLEDEROVÁ. Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration. Disease models & mechanisms. Cambridge: Company of Biologists Ltd., 2020, vol. 13, No 2, p. 1-12. ISSN 1754-8403. Available from: https://dx.doi.org/10.1242/dmm.041319.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration
Authors ARDAN, Taras (203 Czech Republic), Monika BAXA (203 Czech Republic), Božena LEVINSKÁ (203 Czech Republic), Miroslava SEDLÁČKOVÁ (203 Czech Republic, belonging to the institution), The Duong NGUYEN (203 Czech Republic), Jiří KLÍMA (203 Czech Republic), Štefan JUHÁS (203 Czech Republic), Jana JUHÁSOVÁ (203 Czech Republic), Petra ŠMATLÍKOVÁ (203 Czech Republic), Petra VOCHOZKOVÁ (203 Czech Republic), Jan MOTLÍK (203 Czech Republic) and Zdenka ELLEDEROVÁ (203 Czech Republic, guarantor).
Edition Disease models & mechanisms, Cambridge, Company of Biologists Ltd. 2020, 1754-8403.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.758
RIV identification code RIV/00216224:14110/20:00115361
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1242/dmm.041319
UT WoS 000518475500008
Keywords in English Large animal model; TgHD; Brain; Huntingtin; Neuropathology
Tags 14110517, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 15/7/2020 10:26.
Abstract
Recently developed therapeutic approaches for the treatment of Huntington’s disease (HD) require preclinical testing in large animal models. The minipig is a suitable experimental animal because of its large gyrencephalic brain, body weight of 70-100 kg, long lifespan, and anatomical, physiological and metabolic resemblance to humans. The Libechov transgenic minipig model for HD (TgHD) has proven useful for proof of concept of developing new therapies. However, to evaluate the efficacy of different therapies on disease progression, a broader phenotypic characterization of the TgHD minipig is needed. In this study, we analyzed the brain tissues of TgHD minipigs at the age of 48 and 60-70 months, and compared them to wild-type animals. We were able to demonstrate not only an accumulation of different forms of mutant huntingtin (mHTT) in TgHD brain, but also pathological changes associated with cellular damage caused by mHTT. At 48 months, we detected pathological changes that included the demyelination of brain white matter, loss of function of striatal neurons in the putamen and activation of microglia. At 60-70 months, we found a clear marker of neurodegeneration: significant cell loss detected in the caudate nucleus, putamen and cortex. This was accompanied by clusters of structures accumulating in the neurites of some neurons, a sign of their degeneration that is also seen in Alzheimer’s disease, and a significant activation of astrocytes. In summary, our data demonstrate age-dependent neuropathology with later onset of neurodegeneration in TgHD minipigs.
PrintDisplayed: 16/7/2024 23:53